Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Vinay Jeeyar
Observed names:
J. Vinay,
Vinay J,
Vinay J.
Institutions:
National Institute of Science Education and Research,
University of Michigan,
Michigan Medicine
Observed institutions:
National Institute of Science Education and Research,
Homi Bhabha National Institute,
University of Michigan,
Michigan Medicine
ORCID:
0000-0002-3662-8815
Observed ORCID:
0000-0002-3662-8815
OpenAlex ID:
A5089208943
SERPINB5 Genetic Variants rs2289519 and rs2289521 are Significantly Associated with Gallbladder Cancer Risk
2021
·
Biswaheree Mahananda
, J. Vinay
, et al.
·
DNA and Cell Biology
·
14
Association and functional significance of genetic variants present in regulatory elements of SERPINB5 gene in gallbladder cancer
2021
·
Kirti Kumari Sinha
, J. Vinay
, et al.
·
Gene
·
10
Genetic association of MMP14 promoter variants and their functional significance in gallbladder cancer pathogenesis
2021
·
Vinay J.
, Debakanta Mishra
, et al.
·
Journal of Human Genetics
·
10
Functional relevance of MMP2 promoter variants in gallbladder cancer: A case-control study in an Eastern Indian Population
2024
·
Vinay Jeeyar
, Shivaram Prasad Singh
, et al.
·
Gene
·
5
Integrative Molecular Insights Into Epidemiological, Genetic, and Metabolic Risk Factors of Gallbladder Cancer: Implications for Biomarkers, Therapeutic Targeting, and Future Perspectives
2026
·
Deeptima Jaiswar
, Vinay Jeeyar
, et al.
·
Cancer Control
·
4
ISGylation of γH2AX retains MDC1 and facilitates homologous recombination repair causing radioresistance in esophageal adenocarcinoma
2026
·
Archismaan Ghosh
, Paramita Ray
, et al.
·
Journal of Biological Chemistry
·
2
Targeted Therapies in Gallbladder Cancer: Current Status and Future Perspectives
2023
·
Manjusha Dixit
, Vinay J
, et al.
·
Springer eBooks
·
1
GSTT2 Switches from a Homeostatic Antioxidant to a Cell-Cycle-Coupled Factor in Therapy-Resistant Esophageal Adenocarcinoma
2026
·
Daysha Ferrer-Torres
, Paramita Ray
, et al.
·
Cancers
976 Repurposing Statins to Improve Multimodality Therapy in Esophageal Adenocarcinoma Via Mutant P53 and Pd-l1 Targeting
2026
·
Paramita Ray
, Archismaan Ghosh
, et al.
·
Gastroenterology
976 Repurposing Statins to Improve Multimodality Therapy in Esophageal Adenocarcinoma Via Mutant P53 and Pd-l1 Targeting
2026
·
Paramita Ray
, Archismaan Ghosh
, et al.
·
Gastrointestinal Endoscopy
Author response for "Integrative Molecular Insights into Epidemiological, Genetic, and Metabolic Risk Factors of Gallbladder Cancer: Implications for Biomarkers, Therapeutic Targeting, and Future Perspectives"
2026
·
Deeptima Jaiswar
, Vinay Jeeyar
, et al.
·
Publons reviews and discussion
Unveiling the causative role of promoter variant rs113823671 in MMP7 in gallbladder cancer susceptibility
2025
·
Vinay Jeeyar
, Kusumbati Besra
, et al.
·
Scientific Reports
PDF
Show more works
View as search
Works count:
12
Citation count:
46
H-index:
4
I10-index:
3
Year
Topic
Type